The examination of rhabdomyolysis is divided into laboratory examination and imaging examination; laboratory examination includes: myrosinase level measurement, urine routine, blood routine, electrolytes and renal function, etc.; imaging examination includes: MRI (magnetic resonance imaging) of the limbs, etc.
1.Laboratory examination:
(1) Determination of muscle enzyme level: it is the main examination of rhabdomyolysis, most of the patients will have a significant increase in the level of creatine kinase after the appearance of rhabdomyolysis, but there is no standardized criterion for the elevation of the standard value, and clinically, the diagnosis is based on the elevation of the upper limit of the normal value by 5 times.
(2) Urine routine: It is mainly used to clarify whether the urine contains abnormal components such as myoglobin and red blood cells.
(3) Blood routine: This test includes items such as red blood cell count, platelet count and cell classification, etc. The purpose of this test is to observe whether the ratio of components within the blood is abnormal.
(4) Electrolytes: To check calcium, phosphorus, potassium and sodium in the blood to prevent electrolyte disorders and other complications after rhabdomyolysis.
(5) Renal function: Since rhabdomyolysis is most likely to lead to acute renal failure; it is therefore crucial to check creatinine and urea nitrogen levels to determine renal function after the onset of the disease.
(2) Imaging examination: according to the patient’s clinical symptoms, physical examination and other manifestations to initially determine the location of the muscle that has undergone dissolution, prescribe magnetic resonance examination of the relevant parts of the body to assess the degree of muscle necrosis.
Rhabdomyolysis is an acute disease, if there is no obvious cause or a lot of muscle pain after exercise, accompanied by high fever, urine color change and other symptoms, please go to the hospital in time to avoid serious complications such as acute renal failure.